Neutrophil-to-lymphocyte ratio: A crucial determinant of reverse remodeling in patients with heart failure undergoing transcatheter aortic valve implantation?

dc.contributor.authorYalta, Kenan
dc.date.accessioned2024-06-12T11:20:27Z
dc.date.available2024-06-12T11:20:27Z
dc.date.issued2018
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/j.ihj.2018.10.413
dc.identifier.endpageS504en_US
dc.identifier.issn0019-4832
dc.identifier.issn2213-3763
dc.identifier.pmid30595320en_US
dc.identifier.scopus2-s2.0-85059073443en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpageS503en_US
dc.identifier.urihttps://doi.org/10.1016/j.ihj.2018.10.413
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25606
dc.identifier.volume70en_US
dc.identifier.wosWOS:000487586100094en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofIndian Heart Journalen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleNeutrophil-to-lymphocyte ratio: A crucial determinant of reverse remodeling in patients with heart failure undergoing transcatheter aortic valve implantation?en_US
dc.typeLetteren_US

Dosyalar